InsidersTradesSigma
Follow the BioVersys AG share price and the full directors' dealings record of the company, a publicly traded company based in Switzerland. Shares trade on the CH market, under the oversight of SIX SER. Operating in the Health Care sector, BioVersys AG has recorded 6 insider filings. Market capitalisation: €159.7m. The latest transaction was filed on 14 May 2026 (Purchase). All data is openly available.
6
Insider Decl.
n/a
Thresholds
€5,617
4 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioVersys AG Strong Buy (bullish), based on 5 analysts. Average price target: CHF 58.26.
33Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 May 2026
Declarations6 total
1,839 shares@ CHF 1.000.0013% mcap3.6% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q5E00016
1,839 shares@ CHF 1.000.0013% mcap3.5% of flowISIN CH0210362643SIX:T1Q5E00016
1,757 shares@ CHF 28.460.031% mcap96.4% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q5C00085
1,757 shares@ CHF 28.45760.035% mcap93.8% of flowSIX:T1Q5C00085
469 shares@ CHF 1.000.0003% mcap0.9% of flowISIN CH0210362643SIX:T1Q3Q00080
1,000 shares@ CHF 1.001.9% of flowISIN CH0210362643SIX:T1PBH000D0
6 of 6 declarations
About BioVersys AG
BioVersys AG is a biopharmaceutical company focused on developing treatments for resistant bacterial infections. It is listed on the Swiss stock exchange XSWX.